权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Regulation and Consequences of Cytochrome P450 2E1

细胞色素 P450 2E1 的调节和后果

基本信息

批准号：
10713697
负责人：
Jessica Helene Hartman
金额：
$ 36.89万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-01 至 2028-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10713697
关键词：
Acetaminophen Acetone Address Alcoholic liver damage Animal Model Biochemical CYP2E1 gene Cell Compartmentation Cell Culture Techniques Cells Cytochrome P450 Endoplasmic Reticulum Enzymes Epilepsy Ethanol Fatty Acids Genetic Goals Health Human Hydroxylation Knock-out Lipids Liver Metabolic Metabolism Mitochondria Mixed Function Oxygenases Modality Open Reading Frames Organelles Pharmaceutical Preparations Phenotype Population Positioning Attribute Post-Translational Regulation Production Pyruvaldehyde Reaction Reagent Recommendation Regulation Reporting Research Resources Rodent Model Role Stress Tissues Toxic effect Variant Work cell injury diet-induced obesity endoplasm follow-up improved ketogenic diet liver repair loss of function mutation non-alcoholic fatty liver disease pandemic disease pharmacologic polypeptide posttranscriptional programs therapeutic target

项目摘要

PROJECT SUMMARY Cytochrome P450 2E1 (CYP2E1) is a unique, highly conserved, and highly regulated mammalian P450 monooxygenase. CYP2E1 undergoes extensive post-transcriptional and post-translational regulation, including bimodal targeting to endoplasmic reticulum and mitochondria. There are no known loss of function mutations in the human population, and no known polymorphic variants that change the coding region of the protein, indicating an important endogenous role for CYP2E1. However, knockout of CYP2E1 in rodent models has not yielded a dramatic phenotype, and has been reported to be protective against diet-induced obesity, nonalcoholic fatty liver disease, and ethanol-induced toxicity. Therapeutic targeting of CYP2E1 has been recommended for liver repair after alcoholic liver damage and to improve the efficacy of a ketogenic diet for the treatment of epilepsy. However, there remain major gaps in our understanding of the endogenous function of CYP2E1 that must be addressed before CYP2E1 can be safely inhibited in humans, particularly in the long- term. This proposal addresses these challenges using the expertise of the Hartman lab, resources and reagents we have generated to study CYP2E1, and the expertise of our collaborators. The overall goal of the research program is to discover the endogenous function and regulation of CYP2E1 and the consequences of CYP2E1 activity in mitochondria and endoplasmic reticulum. Overview of research and goals for the next five years: The Hartman Lab opened at MUSC during the beginning of the pandemic. It pursues key questions like: How does the cell decide how much CYP2E1 to send to mitochondria vs. the endoplasmic reticulum? Mechanisms of nascent polypeptide targeting will be determined through genetic and pharmacological approaches. What are the endogenous functions of CYP2E1 in multiple tissues? CYP2E1 is known to metabolize acetone to acetol and methylglyoxal, and to hydroxylate fatty acids at the omega and omega-1 position, but these activities have not been studied in the context of overall cellular metabolism and have generally only focused on liver. We are investigating the tissue-specific endogenous functions in multiple tissues. What are the consequences of CYP2E1 expression in mitochondria and endoplasmic reticulum? Emerging evidence in our lab suggests that for ethanol and acetaminophen, mitochondrial CYP2E1 is a liability for drug-induced cellular damage, but for fatty acids, endoplasmic reticular CYP2E1 drives lipid stress. Therefore, there are organelle-specific liabilities that must be further defined. Together this work will address arising and long-standing fundamental questions about CYP2E1.

项目总结